CYP3A inhibitor itraconazole affect pharmacokinetic behavior of famitinib and its active metabolite: results of a single-center, single-arm, open-label and fixed sequence study-Reference-Cited by-同舟云学术

CYP3A inhibitor itraconazole affect pharmacokinetic behavior of famitinib and its active metabolite: results of a single-center, single-arm, open-label and fixed sequence study

Published:2023-12-02 Issue:12 Volume:19 Page:1005-1013
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Huang Yunzhe¹²,Jia Yuanwei¹²,Chen Xinyan²,Wang Changmao¹,Wang Yaqin¹,Wang Minhui¹,Wu Ping¹,Shen Jie¹²

Affiliation:

1. Anhui provincial Center of Drug Clinical Evaluation, Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, People’s Republic of China

2. School of pharmacy, Wannan Medical College, Wuhu, Anhui, People’s Republic of China

Funder

Special Foundation for Talents of Yijishan Hospital

Funding of “Climbing Peak” Training Program for Innovation Technology team of Yijishan Hospital, Wannan Medical College

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2023.2292112

Reference39 articles.

1. Light-inducible receptor tyrosine kinases that regulate neurotrophin signalling

2. Relationships between DNA repair and RTK-mediated signaling pathways

3. Bing Wu. Synthesie and Studies of Famitinib Malate (in chinese). 2011. http://ir.iscas.ac.cn/handle/311060/14883

4. Identification of tyrosine kinase inhibitors from Panax bipinnatifidus and Panax pseudoginseng for RTK—HER2 and VEGFR2 receptors, by in silico approach

5. The Novel Pathogenesis of Retinopathy Mediated by Multiple RTK Signals is Uncovered in Newly Developed Mouse Model

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SIL‐IS LC–ESI–MS/MS method for simultaneous quick detection of amoxicillin and clavulanic acid in human plasma: Development, validation and its application to a pharmacokinetics study;Biomedical Chromatography;2024-09-10

2. Effect of food on the pharmacokinetics and safety profiles of a new PARP inhibitor fuzuloparib capsules in healthy volunteers;Cancer Chemotherapy and Pharmacology;2024-05-04

4. LC–MS/MS method for quick detection of vonoprazan fumarate in human plasma: Development, validation and its application to a bioequivalence study;Biomedical Chromatography;2024-04